Helena Edlund

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Palliative Care

Top Venues

British journal of clinical pharmacology

Clinical pharmacokinetics

AstraZeneca Pharmaceuticals LP

Göteborgs universitet (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca Pharmaceuticals LP

United States

Pharmacometrician :: Quantitative Clinical Pharmacology

Freie Universität Berlin Aug 15 2012 - Aug 30 2015

Germany

PhD Student Pharmacometrics :: Clinical Pharmacy and Biochemistry

Education History

Göteborgs universitet

Sweden

MSC

Publications

Helena Edlund, Núria Buil-Bruna, Karthick Vishwanathan, Helen Wei, Rakesh Raman, Miné de Kock, Zhongqing He, Huan Liu, Marshall Baek, Joseph Ware, Priti Patel, Helen Tomkinson, Shringi Sharma
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignancies. British journal of clinical pharmacology (2021)
Helena Edlund, Francesco Bellanti, Huan Liu, Karthick Vishwanathan, Helen Tomkinson, Joseph Ware, Shringi Sharma, Núria Buil-Bruna
Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP-5862, in patients with B-cell malignancies and in healthy subjects using a population pharmacokinetic approach. British journal of clinical pharmacology (2021)
Helena Edlund, Sun Ku Lee, Marilee A Andrew, J Greg Slatter, Sergey Aksenov, Nidal Al-Huniti
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies. Clinical pharmacokinetics 58 (5) (2020)